Leadiant Biosciences SA in liquidazione;THE UAB RESEARCH FOUNDATION
发明人:
SANDERSON, Ralph D,PRAKASH C. RAMANI, Vishnu,NOSEDA, Alessandro,BARBIERI, Paola,NOSEDA, Alessandro,亞歷山大‧諾塞達,BARBIERI, Paola,保拉‧巴爾維里
申请号：
HK18104587.1
公开号：
HK1245107A
申请日:
2018.04.09
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
The present invention relates to roneparstat for use in a combined therapy for the treatment of multiple myeloma. In particular it has unexpectedly been found that the combined use of roneparstat with a proteasome inhibitor, in particular selected between bortezomib and carfilzomib improve efficacy in decreasing the overall tumor burden, especially showing synergism, with respect to the administration of each active ingredient alone.
